MANDATO, Claudia
 Distribuzione geografica
Continente #
AS - Asia 4.227
NA - Nord America 3.362
EU - Europa 1.182
SA - Sud America 409
AF - Africa 30
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 1
Totale 9.216
Nazione #
US - Stati Uniti d'America 3.299
HK - Hong Kong 2.845
SG - Singapore 605
BR - Brasile 347
IT - Italia 344
CN - Cina 335
RU - Federazione Russa 237
VN - Vietnam 188
UA - Ucraina 161
IE - Irlanda 105
DE - Germania 102
KR - Corea 52
TR - Turchia 51
FI - Finlandia 44
SE - Svezia 44
IL - Israele 41
IN - India 36
GB - Regno Unito 33
AT - Austria 28
CA - Canada 28
MX - Messico 27
AR - Argentina 22
NL - Olanda 22
PL - Polonia 14
BD - Bangladesh 13
ID - Indonesia 13
EC - Ecuador 12
IQ - Iraq 12
CZ - Repubblica Ceca 10
JP - Giappone 10
FR - Francia 9
ZA - Sudafrica 9
ES - Italia 8
CO - Colombia 6
PE - Perù 6
VE - Venezuela 6
EU - Europa 5
PY - Paraguay 5
KE - Kenya 4
PK - Pakistan 4
TN - Tunisia 4
UZ - Uzbekistan 4
BY - Bielorussia 3
LT - Lituania 3
SV - El Salvador 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
MD - Moldavia 2
OM - Oman 2
RO - Romania 2
SA - Arabia Saudita 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CL - Cile 1
DK - Danimarca 1
GE - Georgia 1
GF - Guiana Francese 1
GR - Grecia 1
HR - Croazia 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MA - Marocco 1
ME - Montenegro 1
ML - Mali 1
MW - Malawi 1
PH - Filippine 1
PS - Palestinian Territory 1
RS - Serbia 1
SN - Senegal 1
TL - Timor Orientale 1
UG - Uganda 1
YT - Mayotte 1
Totale 9.216
Città #
Hong Kong 2.839
Ann Arbor 567
Dallas 321
Woodbridge 317
Chandler 288
Princeton 222
Singapore 202
Jacksonville 191
Ashburn 190
Wilmington 167
Houston 146
Dublin 97
Naples 90
Dong Ket 76
Beijing 70
Moscow 50
Los Angeles 43
Nanjing 41
Izmir 40
Dearborn 39
Ho Chi Minh City 38
Andover 35
Boardman 35
Pellezzano 33
Salerno 30
São Paulo 26
Washington 26
Mestre 23
New York 23
Brooklyn 21
Hanoi 21
Munich 19
Vienna 19
Santa Clara 18
Nuremberg 17
Düsseldorf 16
Shenyang 16
Stockholm 16
The Dalles 16
Amsterdam 15
Chicago 14
San Francisco 14
Seattle 14
Council Bluffs 13
Norwalk 13
Pune 13
Atlanta 12
Fairfield 12
Warsaw 12
Denver 11
Montreal 11
Rome 11
Seoul 11
West Jordan 11
Brno 10
Chennai 10
Hebei 10
Jiaxing 10
Rio de Janeiro 10
Tianjin 9
Tokyo 9
Columbus 8
Mexico City 8
Nanchang 8
San Diego 8
Ankara 7
Curitiba 7
Johannesburg 7
London 7
Baghdad 6
Boston 6
Haiphong 6
Lappeenranta 6
Phoenix 6
Arba 5
Biên Hòa 5
Brasília 5
Charlotte 5
Eboli 5
Frankfurt am Main 5
Goiânia 5
Helsinki 5
Manchester 5
Nola 5
Quito 5
Redwood City 5
Ribeirão Preto 5
Shanghai 5
Turku 5
Belo Horizonte 4
Cambridge 4
Caracas 4
Caserta 4
Catania 4
Diadema 4
Edinburgh 4
Esslingen am Neckar 4
Guayaquil 4
Joinville 4
Juiz de Fora 4
Totale 6.908
Nome #
Hepatitis B virus and the paediatric liver: waiting for news on the horizon 724
Liver and Pancreatic Involvement in Children with Multisystem Inflammatory Syndrome Related to SARS-CoV-2: A Monocentric Study 344
Pediatric liver diseases and ocular changes: What hepatologists and ophthalmologists should know and share with each other 340
Multiple gut-liver axis abnormalities in children with obesity with and without hepatic involvement 314
Pediatric parenteral nutrition-associated liver disease and cholestasis: Novel advances in pathomechanisms-based prevention and treatment. 282
Thyroid dysfunction and its role as a risk factor for non-alcoholic fatty liver disease: What's new 238
A systematic review of pediatrics NAFLD therapy: year 2012 211
Metabolomic salivary signature of pediatric obesity related liver disease and metabolic syndrome 203
Refractory primary sclerosing cholangitis becoming responsive after sulphasalazine treatment of an underlying silent colitis 186
Humanization interventions in general pediatric wards: a systematic review 173
A NEW POSSIBLE THERAPEUTIC STRATEGY IN OBESITYRELATED LIVER DISEASE: PRELIMINARY DATA WITH LACTOBACILLUS RHAMNOSUS STRAIN GG 153
Hepatic Presentation of Late-Onset Multiple Acyl-CoA Dehydrogenase Deficiency (MADD): Case Report and Systematic Review 150
Management of adults with paediatric-onset chronic liver disease: Strategic issues for transition care 147
Atypical celiac disease presenting as obesity-related liver dysfunction. 141
Association of Very Rare NOTCH2 Variants with Clinical Features of Alagille Syndrome 138
Antioxidant vitamin E for the treatment of obesità related liver dysfunction in children with poor compliance to hypocaloric diets 135
Autoantibodies against CYP-2C19: A Novel Serum Marker in Pediatric De Novo Autoimmune Hepatitis? 127
Probiotics in the treatment of Non Alcoholic Fatty Liver Disease: Further evidence in obese children 119
LACTOBACILLUS RHAMNOSUS STRAIN GG DESERVES CONSIDERATION AS A THERAPEUTIC TOOL IN OBESITY-RELATED LIVER DISEASE 119
Textbook of liver transplatation. Transition to Adult Care: Adolescents Care 117
Autoimmune manifestations in pediatric liver transplantation recipients 117
Metabolic, hormonal, oxidative, and inflammatory factors in pediatricobesity-related liver disease 114
Autoimmune manifestations in children transplanted for non-autoimmune liver diseases 113
Probiotics: a possible role in treatment of adult and pediatric non alcoholic fatty liver disease 106
More on current evidences on probiotics as a novel treatment for non-alcoholic Fatty liver disease 102
Cytochrome 2C19: a New Hepatic Target of Immune Reactions After Orthopic Liver Transplantation. 101
Cryptogenic liver disease in four children: a novel congenital disorder of glycosylation 99
Analgesic effects of breast- and formula feeding during routine childhood immunizations up to 1 year of age 99
Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions 98
Frequent persistence of hepatic abnormalities in children with hereditary fructose intolerance (HFI) is not correlated to specific gene mutations. 97
Chronic liver disease in two children exposed to moderately high levels of copper in drinking water. 97
Insulin sensitivity and iron metabolism in pediatric obesity related liver disease. 96
Novel congenital disorders of glycosylation may underlie cryptogenic liver disease in children. 96
Gut-liver axis and probiotics: Their role in non-alcoholic fatty liver disease 95
Per-rectal portal scintigraphy is complementary to ultrasonography and endoscopy in the assessment of portal hypertension in children with chronic cholestasis 94
Interplay between metabolic, oxidative, inflammatory and hormonal factors in pediatric obesity related liver disease. 93
Congenital defects of glycosylation may underlie cryptogenic hepatopathy in asymptomatic children 93
Oral vitamin E has beneficial effects on liver disease of obese children unable to loose weight 92
A ZFYVE19 gene mutation associated with neonatal cholestasis and cilia dysfunction: case report with a novel pathogenic variant 91
Chronic ingestion of moderately high copper may cause cryptogenic mild liver disease 90
Non-cirrhotic chronic liver disease in three italian children exposed to moderately high copper intakes 89
Rhabdomyolysis and coeliac disease: A causal or casual association? A case report and review of literature 83
Human Parvovirus B19 Infection in liver transplanted children with chronic hematologic disorders. 82
More on vitamin E therapy 80
Humanization of pediatric care in the world: focus and review of existing models and measurement tools. 80
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) antigen detection in the Emergency Department: data from a pediatric cohort during the fourth COVID-19 wave in Italy 80
Pediatric vs. adult NAFLD to MAFLD transition: a welcome but tangled path 73
Vitamin E treatment in pediatric obesity-related liver disease: a randomized study. 68
Global multi-stakeholder endorsement of the MAFLD definition 64
Outbreak of paediatric myocarditis associated with parvovirus B19 infection in Italy, January to October 2024 63
Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review 62
Three unreported cases of TMEM199-CDG, a rare genetic liver disease with abnormal glycosylation 59
Genotypes and different clinical variants between children and adults in progressive familial intrahepatic cholestasis: a state-of-the-art review 55
Case report: Reversible Fanconi syndrome due to vitamin D deficiency in a patient with epilepsy harbouring a pathogenic variant in the SLC34A1 gene 53
Nutrition and Liver Disease 51
Bassa statura non sindromica e ritardo puberale: non solo ritardo costituzionale di crescita e pubertà 49
Pediatric Fatty Liver and Obesity: Not Always Justa Matter of Non-Alcoholic Fatty Liver Disease 49
Drug dosing in children with obesity: a narrative updated review 48
Liver Involvement in Congenital Disorders of Glycosylation: A Systematic Review 47
Multiple Sclerosis-Related Dietary and Nutritional Issues: An Updated Scoping Review with a Focus on Pediatrics 45
ALAGILLE SYNDROME: IS IT ALWAYS CHOLESTASIS? 45
Ittero e feci ipocoliche: allarme atresia delle vie biliari 45
Case report: Unusual and extremely severe lipoprotein X-mediated hypercholesterolemia in extrahepatic pediatric cholestasis 44
Multisystem inflammatory syndrome in children. An emerging clinical challenge for pediatric surgeons in the COVID 19 era 44
Real-word experience with Odevixibat in children with Progressive Familial Intrahepatic Cholestasis 42
Diagnostic Approach to Acute Liver Failure in Children: A Position Paper by the SIGENP Liver Disease Working Group 42
Clinical heterogeneity of Kabuki syndrome in a cohort of Italian patients and review of the literature 42
Monkeypox Infection 2022: An Updated Narrative Review Focusing on the Neonatal and Pediatric Population 41
Genetics, epigenetics and transgenerational transmission of obesity in children 40
Laryngeal Mask for Minimally-Invasive Surfactant Administration: A Narrative Review 40
The gut-liver axis as a target of liver disease management 40
Systemic Cat-Scratch Disease: a "Troublesome" Diagnosis 39
Frailty in children with chronic liver disease: Growing evidence for an underexplored topic 37
Crohn-Like Colitis in a Young Boy with Hirschsprung Disease 37
Consumptive Hypothyroidism due to Hepatic Hemangiomas: A Case Series and Review of the Literature 36
Cholestatic jaundice in infancy: Struggling with many old and new phenotypes 35
Malnutrition in pediatric chronic cholestatic disease: An up-to-date overview 34
Primary and Secondary Prophylaxis of Gastrointestinal Bleeding in Children with Portal Hypertension: A Multicenter National Study by SIGENP 34
Letter to the Editor in response to: “ZFYVE19 gene mutation: A novel variant of progressive familial intrahepatic cholestasis” 33
Letter to the editor in response to distinguishing autoimmune hepatitis from steatohepatitis in adolescents with obesity and positive screening alanine aminotransferase 33
Diagnostic approach to neonatal and infantile cholestasis: A position paper by the SIGENP liver disease working group 33
A persistent fever associated with elevated inflammatory indices and ultrasound lesions of liver and spleen 33
Reasons why treatment of metabolic dysfunction‐associated steatotic liver disease may benefit from targeting the gut–liver axis as well 33
An odd septic arthritis of the hip 32
Vitamin D Levels in the Pre- and Post-COVID-19 Pandemic Periods and Related Confinement at Pediatric Age 31
Pulmonary lipid modulation: A possible therapeutic target for SARS-CoV-2 infection 31
Acute hepatitis of unknown origin in children: Should we move the discussion from a purely infectious origin also to other plausible causes? 30
Perceptions and Expectations of Youth Regarding the Respect for Their Rights in the Hospital 28
An almost accidentally diagnosis 28
Case Report: Add-on treatment with odevixibat in a new subtype of progressive familial intrahepatic cholestasis broadens the therapeutic horizon of genetic cholestasis 27
Juvenile erythrocytosis in children after liver transplantation: prevalence, risk factors and outcome 27
Isolated aspartate aminotransferase elevation: Is it liver disease or what else? 26
Bronchiolitis: Compliance with guidelines 26
Emerging, re‐emerging and/or atypically behaving infectious diseases 26
The complexity of diagnosing a drug reaction syndrome in the child|La complessità della diagnosi di una sindrome da reazione a farmaco nel bambino 25
Evaluation of non organ specific autoantibodies in children transplanted for non-autoimmune liver diseases 24
Celiac Disease on the Bed-Side: Embedding Case Finding and Screening in Hospitalized Children 24
Thrombotic Features as the Primary Cause of SARS-CoV-2 Related Acute Abdomen in Children 24
Nutritional therapy in liver transplantation 22
The C677T mutation of the 5,1O-methylenetetrahydrofolate reductase gene is a moderate risk factor for spina bifida in Italy 21
Totale 8.958
Categoria #
all - tutte 34.047
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.047


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021269 0 0 0 0 35 9 33 4 50 7 44 87
2021/2022360 5 0 0 3 6 2 1 10 52 39 51 191
2022/2023721 70 51 54 83 78 158 1 56 120 4 35 11
2023/2024533 29 48 43 25 32 89 41 24 14 43 24 121
2024/20251.193 21 22 19 54 42 190 185 100 184 101 175 100
2025/20264.439 375 1.840 1.514 322 388 0 0 0 0 0 0 0
Totale 9.410